FST-100 in the Treatment of Acute Viral Conjunctivitis

Summary

This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.

Timeline

Start

2013-05-17

Primary completion

2014-03-10

Completion

2014-03-10

Drugs

Indications